These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11931153

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.
    Sweetline Anne N, Ronald BSM, Senthil Kumar TMA, Thangavelu A.
    Tuberculosis (Edinb); 2019 Jan; 114():113-118. PubMed ID: 30711149
    [Abstract] [Full Text] [Related]

  • 24. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
    Akhmetova A, Kozhamkulov U, Bismilda V, Chingissova L, Abildaev T, Dymova M, Filipenko M, Ramanculov E.
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
    [Abstract] [Full Text] [Related]

  • 25. Mycobacterium bovis isolates with M. tuberculosis specific characteristics.
    Kubica T, Agzamova R, Wright A, Rakishev G, Rüsch-Gerdes S, Niemann S.
    Emerg Infect Dis; 2006 May; 12(5):763-5. PubMed ID: 16704833
    [Abstract] [Full Text] [Related]

  • 26. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
    Shenai S, Rodrigues C, Sadani M, Sukhadia N, Mehta A.
    Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
    [Abstract] [Full Text] [Related]

  • 27. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S, Fonseca Lde S, Marsico AG, de Oliveira Vieira GB, Sobral LF, Stehr M, Singh M, Saad MH.
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [Abstract] [Full Text] [Related]

  • 28. Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore.
    Lee AS, Tang LL, Lim IH, Wong SY.
    Int J Infect Dis; 2002 Mar; 6(1):48-51. PubMed ID: 12044302
    [Abstract] [Full Text] [Related]

  • 29. Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.
    Rahman A, Ferdous SS, Ahmed S, Rahman SMM, Uddin MKM, Pholwat S, Gratz J, Houpt E, Banu S.
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.
    Mestdagh M, Realini L, Fonteyne PA, Rossau R, Jannes G, Mijs W, DE Smet KA, Portaels F, Van den Eeckhout E.
    Microb Drug Resist; 2000 Sep; 6(4):283-7. PubMed ID: 11272256
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
    Doustdar F, Khosravi AD, Farnia P.
    Microb Drug Resist; 2009 Dec; 15(4):251-6. PubMed ID: 19857130
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of genotype MTBC assay for differentiation of clinical Mycobacterium tuberculosis complex isolates.
    Richter E, Weizenegger M, Rüsch-Gerdes S, Niemann S.
    J Clin Microbiol; 2003 Jun; 41(6):2672-5. PubMed ID: 12791901
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Study of the gyrB gene polymorphism as a tool to differentiate among Mycobacterium tuberculosis complex subspecies further underlines the older evolutionary age of 'Mycobacterium canettii'.
    Goh KS, Fabre M, Huard RC, Schmid S, Sola C, Rastogi N.
    Mol Cell Probes; 2006 Jun; 20(3-4):182-90. PubMed ID: 16517119
    [Abstract] [Full Text] [Related]

  • 37. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y, Zhu D, Zheng H, Shen J, Hu Y, Liu J, Zhao Y.
    BMC Infect Dis; 2017 Nov 06; 17(1):711. PubMed ID: 29110640
    [Abstract] [Full Text] [Related]

  • 38. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
    Sengstake S, Bergval IL, Schuitema AR, de Beer JL, Phelan J, de Zwaan R, Clark TG, van Soolingen D, Anthony RM.
    BMC Infect Dis; 2017 Jul 12; 17(1):491. PubMed ID: 28697808
    [Abstract] [Full Text] [Related]

  • 39. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
    Yüksel P, Tansel O.
    New Microbiol; 2009 Apr 12; 32(2):153-8. PubMed ID: 19579692
    [Abstract] [Full Text] [Related]

  • 40. A multiplex-PCR for the differentiation of Mycobacterium bovis and Mycobacterium tuberculosis.
    Shah DH, Verma R, Bakshi CS, Singh RK.
    FEMS Microbiol Lett; 2002 Aug 27; 214(1):39-43. PubMed ID: 12204370
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.